Cargando…
Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers
BACKGROUND: Many effective treatments for nicotine addiction inhibit noradrenaline reuptake. Three recent studies have suggested that another noradrenaline reuptake inhibitor, atomoxetine, may reduce smoking behaviors. METHODS: The present double-blind, placebo-controlled, fixed-dose study was carri...
Autores principales: | Silverstone, Peter H, Dadashova, Rana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328244/ https://www.ncbi.nlm.nih.gov/pubmed/22405499 http://dx.doi.org/10.1186/1744-859X-11-6 |
Ejemplares similares
-
Off-label use of atomoxetine in adults: is it safe?
por: Dadashova, Rana, et al.
Publicado: (2012) -
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010) -
Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study
por: Adler, Lenard A., et al.
Publicado: (2014) -
Maternal bonding styles in smokers and non-smokers: a comparative study
por: Csala, Iren, et al.
Publicado: (2016) -
Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents
por: Svanborg, Pär, et al.
Publicado: (2009)